Aude Fléchon

25.7k citations
287 papers · 8.1k · 5 hit papers · h-index 34

Impact in

Papers in

    • Testicular diseases and treatments 77
    • Bladder and Urothelial Cancer Treatments 76
    • Urinary and Genital Oncology Studies 32
    • Prostate Cancer Treatment and Research 66
    • Sarcoma Diagnosis and Treatment 26
    • Renal cell carcinoma treatment 25

Aude Fléchon

264 papers receiving 8.0k citations

Aude Fléchon's Hit Papers

TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes 2024 · 45 citations
450+4+9Years since publication10002.0k3.0k

Peers

Aude Fléchon
Comparison fields: 5 of 106
  • Pulmonary and Respiratory Medicine 4.5k
  • Oncology 2.0k
  • Cancer Research 1.1k
  • Surgery 2.0k
  • Radiology, Nuclear Medicine and Imaging 901
Replace Christine Théodore with:
Christine Théodore France
Gwénaëlle Gravis France
Ugo De Giorgi Italy
I. Bodrogi Hungary
Eleni Efstathiou United States
Philippe Beuzeboc France
Mustafa Özgüroğlu Türkiye
Joan Carles Spain
Frédéric Rolland France
Otilia Dalesio Netherlands
Aude Fléchon relative to Christine Théodore France Christine Théodore's profile →
Citations per field
00.5×3.4×
Christine Théodore · 1×
Citations per year

Countries citing papers authored by Aude Fléchon

Since Specialization
Citations

This map shows the geographic impact of Aude Fléchon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aude Fléchon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aude Fléchon more than expected).

Fields of papers citing papers by Aude Fléchon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aude Fléchon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aude Fléchon. The network helps show where Aude Fléchon may publish in the future.

Co-authors

The 25 scholars most cited alongside Aude Fléchon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aude Fléchon Line = papers co-authored together Aude Fléchon links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 287 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Hit paper breakdown →
20123428
2
TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors
Hit paper breakdown →
2021367
3
Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial
Hit paper breakdown →
2018291
4 2020273
5 2011163
6
Randomized Phase III Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, or Gemcitabine and Cisplatin as Perioperative Chemotherapy for Patients with Muscle-invasive Bladder Cancer. Analysis of the GETUG/AFU V05 VESPER Trial Secondary Endpoints: Chemotherapy Toxicity and Pathological Responses
Hit paper breakdown →
2020158
7 2011157
8 1998151
9 2013117
10 2011115
11 2007108
12 200897
13 201972
14 201770
15 201567
16 201166
17 200259
18 202049
19 202046
20 201546

About Aude Fléchon

Aude Fléchon is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 287 papers that have together received 8.1k indexed citations. Recurring topics across this work include Testicular diseases and treatments (77 papers), Bladder and Urothelial Cancer Treatments (76 papers), Prostate Cancer Treatment and Research (66 papers), Cancer Immunotherapy and Biomarkers (35 papers), Urinary and Genital Oncology Studies (32 papers), Radiopharmaceutical Chemistry and Applications (28 papers), Sarcoma Diagnosis and Treatment (26 papers) and Renal cell carcinoma treatment (25 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.5k citations), Oncology (2.0k citations), Cancer Research (1.1k citations), Surgery (2.0k citations) and Radiology, Nuclear Medicine and Imaging (901 citations). Aude Fléchon has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Karim Fizazi, Cora N. Sternberg, Fred Saad, Johann S. de Bono, Kurt Miller, Kim N., Neal D. Shore, Ronald de Wit, Bryan Selby and Mark T. Fleming. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Clinical Genitourinary Cancer and European Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact